Remy
Showing 1–2 of 2 transcripts.
- RAISE Summit20 min
Contentsquare & Eurazeo: From Data Rich to AI Smart Reinventing a Scale Up in Real Time
Anne-Charlotte Filbert, Ilan, Remy
Eurazeo's Anne-Charlotte Filbert and Content Square's Ilan analyzed the latter's strategic pivot from a traditional analytics provider to an AI-native platform following a 2023 acquisition of Heap. Driven by CEO John, the company restructured its organizational culture and product roadmap to prioritize agentic workflows, launching proactive "Sense" insights while implementing strict security protocols for tools like Gemini and Dust. The discussion concluded that future market survival hinges on the "velocity" of leadership to transform late-stage enterprises, contrasting Content Square's scale with the agility required for AI-native success.
- Milken Institute58 min
The Role of Universities in Accelerating Bioscience Research
David Baltimore, Joel Burdick, James Economou, Michael Quick, Owen Witte, Stephen Mayo, Steve Mayo, Nick, Francis Collins, Remy, Joe Boistak, Charles, Eric Green, Ray Deshaies
A consortium of leading academic figures, including Nobel Laureate David Baltimore and experts from Caltech, UCLA, and USC, convened to evaluate the intersection of biological engineering and clinical translation in the face of funding constraints. The panel detailed successful strategies for "engineered immunity" projects, such as converting muscle cells into antibody producers and conducting early-stage human trials within university settings, while highlighting the critical need for interdisciplinary programs that bridge the gap between engineering PhDs and MDs. Despite progress, participants identified a persistent "valley of death" in early-stage financing and urged a cultural shift toward professional management and team-based funding mechanisms to sustain innovation.